Found: 3016
Select item for more details and to access through your institution.
Childhood Arthritis and Rheumatology Research Alliance Biologic Disease‐Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 11, p. 1532, doi. 10.1002/acr.25393
- By:
- Publication type:
- Article
New concepts in the management of adverse drug reactions.
- Published in:
- Allergy & Asthma Proceedings, 2007, v. 28, n. 5, p. 517, doi. 10.2500/aap2007.28.3030
- By:
- Publication type:
- Article
TNF-alpha inhibitors: Current indications.
- Published in:
- Indian Journal of Critical Care Medicine, 2007, v. 11, n. 3, p. 139, doi. 10.4103/0972-5229.35087
- By:
- Publication type:
- Article
Metronidazole as a monotherapy in the management of granulomatous cheilitis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Hidradenitis suppurativa unresponsive to canakinumab treatment: A case report.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Erythrodermic pityriasis rubra pilaris: Dramatic response to infliximab therapy.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Paradoxical reactions induced by tumor necrosis factor-alpha antagonists: A literature review based on 46 cases.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Infliximab: Efficacy in psoriasis.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2013, v. 79, p. S25, doi. 10.4103/0378-6323.115525
- By:
- Publication type:
- Article
Alopecia areata in a patient receiving infliximab.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Infliximab response associates with radiologic findings in bio-naïve Crohn's disease.
- Published in:
- European Radiology, 2023, v. 33, n. 8, p. 5247, doi. 10.1007/s00330-023-09542-y
- By:
- Publication type:
- Article
Pregnancy-Induced Sweet's Syndrome Treated with Infliximab.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Comparative Efficacy and Acceptability of Anti-TNF-Alpha Therapy in Ankylosing Spondylitis: A Mixed-Treatments Comparison.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2016, v. 39, n. 5, p. 1679, doi. 10.1159/000447869
- By:
- Publication type:
- Article
Subkutánní infliximab v léčbě revmatoidní artritidy a ulcerózní kolitidy.
- Published in:
- Remedia, 2023, v. 33, n. 5, p. 395
- By:
- Publication type:
- Article
Komentář ke studii srovnávající dva biosimilární adalimumaby po povinném switchi z originálního přípravku (registr DANBIO).
- Published in:
- Remedia, 2022, v. 32, n. 2, p. 201
- By:
- Publication type:
- Article
Identify Human Cluster of differentiation 147 (CD147), a New Target of SARS-CoV-2 Invasion.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, v. 12, n. 2, p. 2654, doi. 10.31838/ijpr/2020.12.02.359
- By:
- Publication type:
- Article
Vicissitudes In Cellular Immune Related To Anti-Tnf-Alpha Therapy, And Some Clinical Investigation Induces By Infliximab In Covid 19 Patients.
- Published in:
- International Journal of Pharmaceutical Research (09752366), 2020, p. 2264, doi. 10.31838/ijpr/2020.SP1.344
- By:
- Publication type:
- Article
Sarcoidosis Manifestion Centered on the Thalamic Pulvinar Leading to Persistent Astasia.
- Published in:
- Movement Disorders Clinical Practice, 2017, v. 4, n. 6, p. 898, doi. 10.1002/mdc3.12544
- By:
- Publication type:
- Article
Blocking TNF-α with infliximab alleviates ovariectomy induced mechanical and thermal hyperalgesia in rats.
- Published in:
- Neurological Sciences, 2012, v. 33, n. 3, p. 527, doi. 10.1007/s10072-011-0743-9
- By:
- Publication type:
- Article
Biosimilar infliximab versus originator in Crohn's disease anti-TNF-α naïve and non-naïve patients.
- Published in:
- Gastroenterology Review / Przegląd Gastroenterologiczny, 2021, v. 16, n. 3, p. 207, doi. 10.5114/pg.2020.100750
- By:
- Publication type:
- Article
The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn's disease.
- Published in:
- Gastroenterology Review / Przegląd Gastroenterologiczny, 2016, v. 11, n. 3, p. 176, doi. 10.5114/pg.2016.57753
- By:
- Publication type:
- Article
Economic implications of biological therapy for Crohn's disease.
- Published in:
- Gastroenterology Review / Przegląd Gastroenterologiczny, 2015, v. 10, n. 4, p. 197, doi. 10.5114/pg.2015.55749
- By:
- Publication type:
- Article
Pyoderma gangrenosum: guideline for wound practitioners.
- Published in:
- Journal of Wound Care, 2013, v. 22, n. 2, p. 68, doi. 10.12968/jowc.2013.22.2.68
- By:
- Publication type:
- Article
Management of the National Drug Administration Through the Use of Biosimilar Medicines. Expenditures, Numbers of Reimbursed Packages and Shares of Biosimilar Products in the Infliximab Market a Year Prior to and a Year after the Introduction of the National Drug Policy 2018-2022.
- Published in:
- Management Issues / Problemy Zarządzania, 2020, v. 18, n. 3, p. 121, doi. 10.7172/1644-9584.89.7
- By:
- Publication type:
- Article
Listeriosis in patients receiving biologic therapies.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2013, v. 32, n. 9, p. 1225, doi. 10.1007/s10096-013-1873-1
- By:
- Publication type:
- Article
Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2009, v. 28, n. 4, p. 331, doi. 10.1007/s10096-008-0628-x
- By:
- Publication type:
- Article
Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test.
- Published in:
- Oxford Medical Case Reports, 2016, v. 2016, n. 4, p. 94, doi. 10.1093/omcr/omw028
- By:
- Publication type:
- Article
Use of Infliximab to Treat Paradoxical Tuberculous Meningitis Reactions.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 1, p. 1, doi. 10.1093/ofid/ofaa604
- By:
- Publication type:
- Article
1356. A Randomized Controlled Trial of Prednisolone vs. TNF-α inhibitor Infliximab in the Management of Type 1 Lepra Reaction in Leprosy Patients.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S491, doi. 10.1093/ofid/ofz360.1220
- By:
- Publication type:
- Article
Infliximab Biosimilars: A Promising but Unusual Treatment for Mycobacterial Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 3, p. 1, doi. 10.1093/ofid/ofx164
- By:
- Publication type:
- Article
The Efficacy of Infliximab Monotherapy versus Infliximab-Azathioprine Sequential Treatment in Crohn’s Disease: Experience from a Tertiary Medical Center in China.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/8648307
- By:
- Publication type:
- Article
Effect of Anti-TNF Antibodies on Clinical Response in Rheumatoid Arthritis Patients: A Meta-Analysis.
- Published in:
- BioMed Research International, 2016, v. 2016, p. 1, doi. 10.1155/2016/7185708
- By:
- Publication type:
- Article
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 6, p. 948, doi. 10.3390/jpm12060948
- By:
- Publication type:
- Article
Pharmacokinetic Similarity of ABP 710, a Proposed Biosimilar to Infliximab: Results From a Randomized, Single‐Blind, Single‐Dose, Parallel‐Group Study in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 2, p. 246, doi. 10.1002/cpdd.738
- By:
- Publication type:
- Article
Proteomic Analysis of Potential Targets for Non-Response to Infliximab in Patients With Ulcerative Colitis.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.905133
- By:
- Publication type:
- Article
Infliximab for Paradoxical Reactions in Pediatric Central Nervous System Tuberculosis.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 12, p. 1087, doi. 10.1093/jpids/piab094
- By:
- Publication type:
- Article
Relationship between serum infliximab trough levels and endoscopic activities in patients with Crohn's disease under scheduled maintenance treatment.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 4, p. 674, doi. 10.1007/s00535-013-0829-7
- By:
- Publication type:
- Article
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 2, p. 254, doi. 10.1007/s00535-013-0807-0
- By:
- Publication type:
- Article
The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFα monoclonal antibodies.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 1, p. 156, doi. 10.1007/s00535-013-0872-4
- By:
- Publication type:
- Article
Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry.
- Published in:
- Journal of Gastroenterology, 2012, v. 47, n. 4, p. 359, doi. 10.1007/s00535-011-0499-2
- By:
- Publication type:
- Article
Development of a new immunoassay for the accurate determination of anti-infliximab antibodies in inflammatory bowel disease.
- Published in:
- Journal of Gastroenterology, 2012, v. 47, n. 2, p. 136, doi. 10.1007/s00535-011-0474-y
- By:
- Publication type:
- Article
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
- Published in:
- Journal of Gastroenterology, 2011, v. 46, n. 2, p. 129, doi. 10.1007/s00535-010-0352-z
- By:
- Publication type:
- Article
Prospective clinical trial: enteral nutrition during maintenance infliximab in Crohn’s disease.
- Published in:
- Journal of Gastroenterology, 2010, v. 45, n. 1, p. 24, doi. 10.1007/s00535-009-0136-5
- By:
- Publication type:
- Article
Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab.
- Published in:
- Journal of Gastroenterology, 2008, v. 43, n. 5, p. 397, doi. 10.1007/s00535-008-2165-x
- By:
- Publication type:
- Article
Inflixmab as a possible treatment for the hemorrhagic type of Crohn’s disease.
- Published in:
- Journal of Gastroenterology, 2004, v. 39, n. 3, p. 284, doi. 10.1007/s00535-003-1290-9
- By:
- Publication type:
- Article
A Case of Immunotherapy-Induced Colitis Complicated by Perforation and Treated with Infliximab Postoperatively.
- Published in:
- Case Reports in Oncological Medicine, 2019, p. 1, doi. 10.1155/2019/9069354
- By:
- Publication type:
- Article
Granulomatous Hepatitis Secondary to Histoplasma Infection after Treatment with Infliximab.
- Published in:
- Case Reports in Hepatology, 2013, p. 1, doi. 10.1155/2013/807537
- By:
- Publication type:
- Article
Hepatitis B Virus Reactivation Induced by Infliximab Administration in a Patient with Crohn's Disease.
- Published in:
- Case Reports in Hepatology, 2013, p. 1, doi. 10.1155/2013/461879
- By:
- Publication type:
- Article
Chronic Genotype 3 Hepatitis E in Pregnant Woman Receiving Infliximab and Azathioprine.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Nontuberculous Mycobacteria Infections and Anti-Tumor Necrosis Factor-α Therapy.
- Published in:
- Emerging Infectious Diseases, 2009, v. 15, n. 10, p. 1556, doi. 10.3201/eid1510.090310
- By:
- Publication type:
- Article
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab.
- Published in:
- Journal of NeuroVirology, 2012, v. 18, n. 1, p. 55, doi. 10.1007/s13365-012-0078-1
- By:
- Publication type:
- Article